Takara Bio Europe today announced that it has joined forces with leading qPCR training provider TATAA Biocenter to offer free educational webinars in real-time PCR (qPCR) for academic and industrial researchers and laboratory technicians.
21 February, 2012
Cancer Research UK scientists have revealed how a combination of two very different drugs, currently being tested in clinical trials, amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today (Monday).
20 February, 2012
Xceleron, a leader in accelerating drug development using ultra-sensitive bioanalytical analyses, announced that existing investors Albion Ventures and Solon Ventures have invested US$2.4MM to locate all of the company’s business in its custom-built facility in Germantown, MD which is expected to be fully operational by 31st March 2012.
16 February, 2012
The Scottish Medicines Consortium (SMC) has issued positive final guidance for RoActemra, the UK’s first specifically licensed, effective biologic treatment for systemic juvenile idiopathic arthritis (SJIA).
14 February, 2012
The most recent issue of Drug Discovery Today: Therapeutic Strategies, edited by Chris Lipinski, deals with the exciting topic of drug repurposing. The twelve articles selected for this issue were intended to highlight the “state-of-the-art” of this growing discipline.
13 February, 2012
GlaxoSmithKline Pty Ltd (GSK) announced that it will invest $60 million to expand its manufacturing and new drug development activities in Victoria, Australia. The investment by one of the world’s leading pharmaceutical companies will create 58 new highly-skilled jobs by 2017.
08 February, 2012
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
07 February, 2012
Medicinal chemistry is the theme of this month’s issue of Drug Discovery Today’s Editor’s Choice newsletter. Medicinal chemistry is a complex science at the heart of drug discovery, drug design and drug hunting. It is the art of generating ‘molecules with function’ - lead compounds with potential for future drugs and optimizing these iteratively into medicines for unmet medical need.
06 February, 2012
Psychiatric drugs are as effective as drugs used to treat many physical health problems, according to a major review published in the February issue of the British Journal of Psychiatry.
01 February, 2012